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Professor Mladen Mintas, Ph. D. (from the Faculty of 
Chemical Engineering and Technology, University of 
Zagreb, Croatia) continues to produce topical 
monographs alone or in collaboration with his 
colleagues. The present monograph Medicinska kemija 
protutumorskih lijekova [Medicinal Chemistry of 
Antitumouric Drugs] is his fourth topical monograph. 
His previous three monographs were Načela 
dizajniranja lijekova [Principles of Drug Design, 
HINUS, Zagreb, 2000, 202 pages, ISBN 953-97716-6-
8], prepared in collaboration with Silvana Raić-Malić 
and Nenad Raos, Lijekovi u prostoru – farmakofori i 
receptori [Drugs in the Space – Pharmacophores and 
Receptors, Školska knjiga d.d., Zagreb, 2005, 230 
pages, ISBN 953-0-31566-X], prepared again in 
collaboration with Silvana Raić-Malić and Nenad Raos, 
and Medicinska kemija [Medicinal Chemistry, 
Medicinska naklada, Zagreb, 2009, 415 pages, ISBN 
978-953-176-410-0]. The reviews of these three mono-
graphs appeared in this journal: the first two books were 
reviewed in 2007, see Croat. Chem. Acta 80 (2007) A1, 
and the third book was reviewed in 2010, see Croat. 
Chem. Acta 83 (2009) CCVII. 
The present monograph Medicinska kemija 
protutumorskih lijekova (Medicinal Chemistry of 
Antitumouric Drugs) consists of Preface, Introduction, 
10 chapters, Glossary of Concepts and the author’s brief 
Curriculum Vitae. The target of this monograph is to 
present the modern approaches, based on the medicinal 
chemistry, to the development of anti-cancer drugs. The 
first chapter is entitled Rak i kemoterapija raka (Cancer 
and the Cancer Chemoteraphy, pp. 1–13). In this chap-
ter is discussed the cancer etiology, molecular mecha-
nisms of the cancer dysregulation, chemistry and the 
development of anti-tumouric drugs, the cancer chemo-
therapy, strategies in the development of anti-tumouric 
chemotherapeutics and the use of nanotechnology in the 
cancer chemotherapy. 
The next eight chapters present the action of che-
motherapeutics on a given biological target. The second 
chapter is entitled Antimetaboliti (Antimetabolites, pp. 
15–39). The third chapter is entitled Struktura i svojstva 
DNA (The Structure and Properties of DNA, pp. 41–53). 
Note, the Croatian abbreviation of DNA is DNK. The 
author should have used DNK in the title of this and the 
next chapter. The fourth chapter is entitled Lijekovi koji 
interferiraju s DNA (The Drugs that Interfere with DNA, 
pp. 55–89). The fifth chapter is entitled Protutumorski 
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antibiotici (Antitumouric Antibiotics, pp. 91–113). 
The sixth chapter is entitled Inhibitori stvaranja 
mikrotubula (Inhibitors of the Mycrotubular Creation, 
pp. 115-121). The seventh chapter is entitled Selektivni 
modulatori estrogenskih receptora (Selective Modula-
tors of Estrogenic Receptors, pp. 123–137). The eighth 
chapter is entitled Inhibitori proteinske i receptorske 
kinaze (Inhibitors of Protein and Receptor Kinase, pp. 
139–153). The ninth chapter is entitled Inhibitori 
proteasoma u kemoterapiji raka (Proteasome Inhibitors 
in the Cancer Chemotherapy, pp. 155–159).  
The tenth and the last chapter is entitled Buduć-
nost razvoja protumorskih lijekova (The Future of the 
Antitumouric Drug Developments, pp. 161–213). This 
is the largest chapter in the book presenting possible 
developments in designing the antitumouric drugs. In 
this chapter I noticed an interesting subchapter on the 
use of teratogenic drug thalidomide in treating multiple 
myeloma. 
The monograph ends with Pojmovnik (Glossary of 
Concepts, pp. 215–225) and Životopis (the author's 
biography, p. 227). Each chapter is followed by selected 
references. The total number of references in the 
monograph is 218. The monograph is well-written and 
nicely complemented with beatiful illustrations. This is 
inded a very attractive book. 
The monograph Medicinska kemija 
protutumorskih lijekova (Medicinal Chemistry of 
Antitumouric Drugs) is aimed to undergraduate and 
graduate students of all faculties which offer courses in 
organic chemistry, biochemistry and bioorganic 
chemistry. I recommend this monograph to all who are 
interested in the modern medicinal chemistry and its 
uses in developing drugs for the treatment of various 
forms of cancer. 
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